Skip navigation
|
Home
Contact us
Urdu
Confidential Helpline
0845 223 4424
[
Viewing options
]
Search
Hepatitis C Info
Treatment
Living with Hep C
Support
Get Involved
News & Resources
The Trust
News
Media centre
Resources
Trust Updates
Glossary
Community Links
News
2012
May
April
March
February
January
Benefits Hepatitis and HIV
Can adding vitamin D improve response to HCV antiviral therapy?
Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers
Hair we go says loving daughter
New report published - HIV and Hepatitis C Co-infection
Entry point of hepatitis C virus identified
High Rate of Sustained Response with Interferon Free Daclatasvir + Asunaprevir
Achillion, Presidio, Idenix Announce HCV Drug Pipeline Developments
Discussion on potential vaccine for hepatitis C
Experts Issue Provisional Guidance on New Hepatitis C Drugs for HIV/HCV Coinfected Patients
Fever Signals Responsiveness to Pegylated Interferon for Hepatitis C
HCV ALL Oral Therapy Cured Without Peg/Rbv
Hep C vaccine trial 'promising'
Hepatitis B and C Are Major Causes of Liver Cancer
Hepatitis C drug set to give Cardiff University financial boost
Hepatitis C Virus Hijacks Liver microRNA
How A New Antiviral Works
More support for people with hepatitis C
Scientists show brain vulnerable to Hepatitis C virus
Sustained Response in Patients Treated with Telaprevir
2011
2010
2009
2008
2007
2006
2005
2004
Home
>
News & Resources
>
News
>
2012
>
January
January
Benefits Hepatitis and HIV
Can adding vitamin D improve response to HCV antiviral therapy?
Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers
Hair we go says loving daughter
New report published - HIV and Hepatitis C Co-infection
Entry point of hepatitis C virus identified
High Rate of Sustained Response with Interferon Free Daclatasvir + Asunaprevir
Achillion, Presidio, Idenix Announce HCV Drug Pipeline Developments
Discussion on potential vaccine for hepatitis C
Experts Issue Provisional Guidance on New Hepatitis C Drugs for HIV/HCV Coinfected Patients
Fever Signals Responsiveness to Pegylated Interferon for Hepatitis C
HCV ALL Oral Therapy Cured Without Peg/Rbv
Hep C vaccine trial 'promising'
Hepatitis B and C Are Major Causes of Liver Cancer
Hepatitis C drug set to give Cardiff University financial boost
Hepatitis C Virus Hijacks Liver microRNA
How A New Antiviral Works
More support for people with hepatitis C
Scientists show brain vulnerable to Hepatitis C virus
Sustained Response in Patients Treated with Telaprevir
Hepatitis Info
About hep C
Just diagnosed?
Risk factors
Stages of hep C
Considering a test
Symptoms
Cirrhosis
Treatment
Considering
Choosing
Side effects
Preparing for treatment
New drugs
Interferon and ribavirin
Living with
Caring for yourself
Prevention
Mental and emotional
Alternative Medicine
Doctors and Consultants
Support
Support Groups
The importance of support
Helpline
Advocacy
Skipton fund
News & Resources
Resources
Newsletter
Media centre
Get Involved
Volunteering
Fundraising
Campaigning
Become a member
Get tested!
World hepatitis day
Personal stories
About us
Contact us
The team
The work we do
Donate
Resources
Media
About the Trust
[
Sign In
]
[
Sign Up
]